戻る Agenda
Global Symposium
Session Chair(s)
Barry Mangum, PHARMD
Chief Executive Officer
Paidion Research, Inc., United States
Early Development of New Drugs in Latin America
Learning Objective : Discuss China regulatory guidelines for a first-in-human study; Describe the regulatory framework of translational researches in the Asia Pacific region; Discuss how early development of new drugs is being conducted in Latin America.
Speaker(s)
Would China Be Ready for First-in-human Study in Global R&D Strategy?
Jack Xu, MD, MS
Shanghai Clinical Research Center (SCRC), China
Senior Vice President
Impacts to Global Development from Paradigm Shifts of Regional Cooperation of Translational Researches in the Asia Pacific Region
Chih-Hwa Wallace Lin, PHD
Board of Science and Technology, Executive Yuan, ROC, Taiwan
Researcher and Acting Director, Biotechnology Unit
Early Development of New Drugs in Latin America
João Massud, MD
Brazilian Society of Pharmaceutical Medicine (SBMF), Brazil
Senior Consultant, Drug Development